Immunoradiometric assay of total PSA, Free PSA and PSA ratio calculation in prostatic cancer (PCa) diagnosis

被引:0
|
作者
Giovanella, L [1 ]
Erba, P [1 ]
Ceriani, L [1 ]
Vio, P [1 ]
Garancini, S [1 ]
机构
[1] Azienda Osped Osped Circolo, Dept Nucl Med, Varese, Italy
关键词
D O I
暂无
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Total PSA assay is a well established procedure for biochemical evaluation and management of PCa which usefulness in its diagnosis is limited by its weak specificity with regard to BPH. Recently the assay of Free- PSA and the calculation of Free/Total-PSA Ratio has been suggested to improve the specificity of PSA in the range of concentrations between 2.5 and 20 ng/mL. We evaluated the diagnostic performance of PSA-Ratio among untreated patients with PSA levels ranging from 2.5 to 20 ng/mL and histological diagnosis of PCa or BPH. As the ROC curves analysis stowed PSA-Ratio is the better parameter to discriminate between PCa and BPH: PSA-Ratio could be employed to enhance the diagnostic performance of PSA alone in PCa diagnosis.
引用
收藏
页码:497 / 500
页数:4
相关论文
共 50 条
  • [1] Correlation between the Complex PSA/total PSA Ratio and the Free PSA/total PSA Ratio, Sensitivity and Specificity of Both Markers for the Diagnosis of Prostate Cancer
    Perez-Lanzac-Lorca, A.
    Barco-Sanchez, A.
    Romero, E.
    Martinez-Peinado, A.
    Lopez-Elorza, F.
    Sanchez-Sanchez, E.
    Alvarez-Ossorio-Fernandez, J. L.
    Castineiras-Fernandez, J.
    [J]. ACTAS UROLOGICAS ESPANOLAS, 2013, 37 (08): : 498 - 503
  • [2] Use of the Tandem(R) PSA ratio (free/total PSA) in distinguishing between prostate cancer (PCA) and benign prostatic hyperplasia (BPH).
    Southwick, PC
    Catalona, WJ
    Partin, AW
    Ratliff, TL
    Chan, DW
    Walsh, PC
    Subong, ENP
    Kelley, CA
    Gasior, GH
    [J]. CLINICAL CHEMISTRY, 1996, 42 (06) : 667 - 667
  • [3] Total PSA, free PSA/total PSA ratio, and molecular PSA detection in prostate cancer: Which is clinically effective and when?
    Basso, D
    Fogar, P
    Piva, MG
    Navaglia, F
    Mazza, S
    Prayer-Galetti, T
    Castellucci, E
    Pagano, F
    Plebani, M
    [J]. UROLOGY, 2000, 55 (05) : 710 - 715
  • [4] The clinical value of free PSA and total PSA ratio
    Dalva, I
    Akan, H
    Zincirci, C
    Bingol, N
    [J]. 5TH MEDITERRANEAN CONGRESS OF UROLOGY, 1997, : 19 - 24
  • [6] Afssaps market survey of total PSA, free PSA and complexed PSA assay kits
    [J]. PROGRES EN UROLOGIE, 2007, 17 (02): : 176 - 176
  • [7] Predictive value in prostatic adenocarcinoma of PSA, Free vs. Total PSA, and PSA density
    Knight, RJ
    Khan, FA
    Jarmulowicz, M
    Kennedy, AM
    St George, D
    Kaisary, AV
    [J]. BJU INTERNATIONAL, 2005, 95 : 20 - 20
  • [8] Validity of PSA, free/total PSA ratio and complexed/total PSA ratio measurements in men with acute urinary retention
    Sriprasad, S
    Dew, TK
    Muir, GH
    Thompson, PM
    Mulvin, D
    Choi, WH
    Dickinson, IK
    Sherwood, RA
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2001, 4 (03) : 167 - 172
  • [9] Validity of PSA, free/total PSA ratio and complexed/total PSA ratio measurements in men with acute urinary retention
    S Sriprasad
    TK Dew
    GH Muir
    PM Thompson
    D Mulvin
    WH Choi
    IK Dickinson
    RA Sherwood
    [J]. Prostate Cancer and Prostatic Diseases, 2001, 4 : 167 - 172
  • [10] Clinical evaluation of free PSA total PSA (prostate-specific antigen) ratio in the diagnosis of prostate cancer
    Filella, X
    Alcover, J
    Molina, R
    Rodriguez, A
    Carretero, P
    Ballesta, AM
    [J]. EUROPEAN JOURNAL OF CANCER, 1997, 33 (08) : 1226 - 1229